Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Psychedelics Field Trip administers new synthetic molecule in Australia Initial dose of FT-104 given in Adelaide, company announces name change Rowan DunneJuly 22, 2022
Psychedelics Delic Holdings highlights financial success and continues expanding KWC Canadian company continues to develop its presence in the clinical psychedelic sector Rowan DunneJuly 21, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022
Business Numinus reports sequential revenue dip of 5.7% The drop was due to a shift in Numinus Bioscience operations Natalia Buendia CalvilloJuly 15, 2022
Psychedelics MAPS now providing digital psychedelic education Psychedelic Fundamentals course to provide broad overview of a vast topic Rowan DunneJuly 14, 2022
Psychedelics Filament Health undertakes innovative clinical trial FDA-approved psilocin study in California said to be first of its kind for industry Rowan DunneJuly 11, 2022
Psychedelics UBC graduates launch promising psychedelics startup in Nevada Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing new therapies Rowan DunneJuly 8, 2022
Psychedelics Nirvana Life acquires exclusive license for novel psychedelic delivery system Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector Rowan DunneJuly 6, 2022
Psychedelics PSYC Corp makes successful psychedelic investments Company stock portfolio appreciates significantly since January 2021 Rowan DunneJuly 5, 2022